As of 28 Aug 2026, Suven Life Sciences Ltd share price is ₹367.70. The stock opened at ₹367.70 and had closed at ₹371.85 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹124.35 and a high of ₹393.00. In terms of performance, Suven Life Sciences Ltd share price has increased by 145.22% over the past six months and has increased by 72.87% over the last year.
SUVEN Charts
Suven Life Sciences Ltd Overview
About SUVEN
Suven Life Sciences is a clinical-stage biopharmaceutical Group focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders. The goal is to be the leading biopharmaceutical Group focused on the treatment of dementia, a condition characterised by a significant decline in mental capacity and impaired daily function.
Suven Life Sciences Ltd Historical Performance
Suven Life Sciences Ltd Fundamental Analysis
Suven Life Sciences Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 11.09 | 8.30 | 5.58 | 4.70 | 2.46 |
| EBITDA | -13.48 | -9.43 | -12.12 | -14.13 | -13.41 |
| Net Profit | -16.12 | -11.17 | -13.47 | -15.45 | -14.78 |
| EPS | -0.61 | -0.50 | -0.60 | -0.70 | -0.68 |
Suven Life Sciences Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 62.92 |
| MACD | 14.54 |
| 20-Day SMA | 335.83 |
Suven Life Sciences Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Suven Life Sciences Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,800.00+0.38% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,009.00+0.40% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹915.65+0.20% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Suven Life Sciences Ltd today is ₹367.70 on NSE and ₹367.70 on BSE.
- The 52-week high of Suven Life Sciences Ltd is ₹393.00, while the 52-week low is ₹124.35.
- The current market capitalisation of Suven Life Sciences Ltd is approximately ₹10,390 crore.
- The P/E (Price-to-Earnings) ratio of Suven Life Sciences Ltd is -11.32. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Suven Life Sciences Ltd is 9.11. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Suven Life Sciences Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Suven Life Sciences Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Suven Life Sciences Ltd has delivered a return of approximately 462.15%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Suven Life Sciences Ltd comprises different categories of shareholders. As of Jul 2026, the shareholding is approximately 65.47% promoters, 0.47% FIIs, 2.73% DIIs, and 24.40% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
